Edition:
United Kingdom

People: Smith & Nephew PLC (SN.L)

SN.L on London Stock Exchange

1,916.50GBp
20 Aug 2019
Change (% chg)

-- (--)
Prev Close
1,916.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,985,139
52-wk High
1,943.50
52-wk Low
1,242.50

Padmanabhan, Vasant 

Dr. Vasant Padmanabhan is President - Research & Development of the Company. He joined Smith & Nephew in August 2016 and is responsible for Research and Innovation, New Product Development, Safety Affairs, Clinical Affairs, Medical device/Pharmacovigilance and Clinical Operations. He is based in Andover, US. Skills and Experience Vasant brings extensive experience in R&D and technology. Prior to Smith & Nephew, Vasant was Senior Vice President of Technical Operations at Thoratec Corporation, a leader in mechanical circulatory support solutions for the treatment of heart failure. In this role, he provided leadership to a 600 member team, with responsibility for global R&D, Programme Management, Operations and Quality. Prior to Thoratec, Vasant had an 18-year career at Medtronic, starting as a Staff Scientist and, progressing through more senior roles, ultimately becoming Vice President of Product Development for the Implantable Defibrillator Business. Vasant holds a Ph.D degree in Biomedical Engineering from Rutgers University, US and an MBA degree from the Carlson School of Management, Minnesota.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --